Novacyt: Biosynex holds 3% of capital and votes


(CercleFinance.com) – Novacyt announces that Biosynex notified it on February 14, 2022 that as of February 10, 2022, Biosynex’s stake in the Company on the basis of vote and capital is 3.0012%.

Copyright © 2022 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.





Facebook


LinkedIn


E-mail





Source link -85